MedPath
HSA Product

NEODOL INJECTION 25 mg/ml

Product approved by Health Sciences Authority (SG)

Basic Information

NEODOL INJECTION 25 mg/ml

INJECTION

Regulatory Information

SIN09444P

July 16, 1997

Prescription Only

Therapeutic

INTRAMUSCULAR

August 10, 2023

June 3, 2025

XM01AB05

Company Information

NAINA MOHAMED & SONS PRIVATE LIMITED

NAINA MOHAMED & SONS PRIVATE LIMITED

Active Ingredients

DICLOFENAC SODIUM

Strength: 25 mg/ml

Detailed Information

Contraindications

**Contraindications:** Diclofenac Sodium is contraindicated in patients with history of Hypersensitivity, active peptic ulcer or Gastrointestinal bleeding, and those who are known to develop asthma, urticaria or other allergic reactions with aspirin or other NSAID's. Acute porphyria is a contraindication for Diclofenac. The use of high dose diclofenac (150mg/day) for more than 4 weeks is contraindicated in patients with established cardiovascular disease (congestive heart failure, established ischemic heart disease, peripheral arterial disease) or uncontrolled hypertension.

Indication Information

**Indications:** Relief of pain and inflammation in condition such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, renal colic, acute gout.

© Copyright 2025. All Rights Reserved by MedPath